End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.7 CNY | +0.82% | +1.80% | -4.85% |
Apr. 10 | Chongqing Pharscin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Apr. 03 | Pharscin Pharma Gets License to Produce Olmesartan Medoxomil Amlodipine Tablets | MT |
Sales 2021 | 846M 117M | Sales 2022 | 785M 109M | Capitalization | 8.5B 1.18B |
---|---|---|---|---|---|
Net income 2021 | 91M 12.6M | Net income 2022 | 98M 13.57M | EV / Sales 2021 | 8.26 x |
Net cash position 2021 | 259M 35.92M | Net cash position 2022 | 503M 69.68M | EV / Sales 2022 | 10.2 x |
P/E ratio 2021 |
78.9
x | P/E ratio 2022 |
83.4
x | Employees | 1,416 |
Yield 2021 |
0.28% | Yield 2022 |
0.34% | Free-Float | 9.66% |
1 day | +0.82% | ||
1 week | +1.80% | ||
Current month | +1.80% | ||
1 month | +3.30% | ||
3 months | +30.43% | ||
6 months | -12.34% | ||
Current year | -4.85% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Ying Liu
CEO | Chief Executive Officer | 61 | 15-08-18 |
Kai Yu Xu
CHM | Chairman | 58 | 00-09-30 |
Xiao Yan Peng
DFI | Director of Finance/CFO | 50 | 02-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jia Ming Li
BRD | Director/Board Member | 58 | 22-05-17 |
Shou Ying Du
BRD | Director/Board Member | 64 | 20-04-30 |
Hong Tao You
CHM | Chairman | 61 | 15-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 14.7 | +0.82% | 3,171,100 |
24-05-06 | 14.58 | +0.97% | 3,613,800 |
24-04-30 | 14.44 | +1.83% | 4,218,309 |
End-of-day quote Shenzhen S.E., May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-4.85% | 845M | |
+20.39% | 43.95B | |
+20.68% | 22.49B | |
+11.68% | 14.71B | |
+11.13% | 13.77B | |
+41.83% | 12.3B | |
-9.22% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B |
- Stock Market
- Equities
- 002907 Stock